Valuation: Incyte Corporation

Market Cap 26.29B 22.57B 21.18B 19.35B 36.51B 2,508B 36.69B 251B 97.15B 1,265B 98.73B 96.58B 4,190B P/E 2026 *
57.9x
P/E 2027 * 17.9x
Enterprise Value 22.06B 18.94B 17.77B 16.23B 30.64B 2,104B 30.79B 210B 81.52B 1,062B 82.84B 81.05B 3,516B EV / Sales 2026 *
3.71x
EV / Sales 2027 * 3.24x
Free-Float
98.16%
Yield 2026 *
-
Yield 2027 * -
1 day-0.69%
1 week+0.22%
Current month+7.73%
1 month+8.32%
3 months+32.60%
6 months+28.64%
Current year+30.36%
1 week 125.6
Extreme 125.6
130.8
1 month 115.77
Extreme 115.77
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
19/8/26 Sell

Chairperson

-10,801 0.0053%
12/8/26 Sell

Chairperson

-10,803 0.0053%
5/8/26 Fiscal year

EVP & Chief Scientific Officer

6,621 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%+0.22%+53.28%+98.60% 26.29B
-1.31%-2.07%+40.12%-0.90% 83.24B
-7.34%-15.13%+498.42%+30.01% 63.41B
-0.69%+3.58%-19.85%-35.64% 59.49B
+0.76%+3.53%+0.08%+36.18% 52.94B
-1.38%+1.47%+10.64%+168.92% 49.86B
-0.28%-0.38%+61.44%-16.73% 32.62B
+9.69%+13.61%+9.85%+224.85% 22.23B
-1.15%-0.30%+60.29%+121.68% 17.22B
-0.38%-4.66%+63.78%+179.18% 15.72B
Average -0.27%+18.14%+77.81%+80.62% 42.3B
Weighted average by Cap. -1.13%+26.23%+94.47%+52.01%

Financials

2026 *2027 *
Net sales 5.94B 5.1B 4.79B 4.37B 8.25B 567B 8.29B 56.65B 21.95B 286B 22.31B 21.83B 947B 6.27B 5.38B 5.05B 4.61B 8.7B 598B 8.74B 59.73B 23.15B 301B 23.52B 23.01B 998B
Net income 466M 400M 375M 343M 647M 44.43B 650M 4.44B 1.72B 22.41B 1.75B 1.71B 74.24B 1.5B 1.28B 1.21B 1.1B 2.08B 143B 2.09B 14.26B 5.53B 71.98B 5.62B 5.49B 238B
Net Debt -4.23B -3.63B -3.41B -3.11B -5.87B -403B -5.9B -40.32B -15.63B -204B -15.88B -15.54B -674B -5.99B -5.14B -4.83B -4.41B -8.32B -571B -8.36B -57.12B -22.13B -288B -22.49B -22.01B -955B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
27/08/26 US$128.76 -0.74% 190,979
25/08/26 US$129.72 +1.36% 1,162,238
24/08/26 US$127.98 +0.13% 799,608
21/08/26 US$127.81 +0.46% 1,367,411
20/08/26 US$127.22 -0.97% 1,207,144
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
129.72USD
Average target price
127.12USD
Spread / Average Target
-2.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock